You have 9 free searches left this month | for more free features.

Severe Acute Respiratory Syndrome CoronaVirus 2

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Respiratory Distress Syndrome, Adult Trial in United States (Veru-111)

Completed
  • Respiratory Distress Syndrome, Adult
  • Scottsdale, Arizona
  • +4 more
Nov 22, 2021

Corona Virus Disease 19 (Covid19), Corona Virus Infection, Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2) Trial in

Completed
  • Corona Virus Disease 19 (Covid19)
  • +2 more
  • Cairo, Egypt
    Al Assema Hospital
Apr 25, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Trial (COVAC-1, Saline Placebo)

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  • COVAC-1
  • Saline Placebo
  • (no location specified)
Jan 23, 2023

Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive Trial in Orange, Sacramento, San Diego (Isavuconazonium

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • Aspergillosis Invasive
  • Isavuconazonium Injection [Cresemba]
  • Placebo
  • Orange, California
  • +2 more
Jul 26, 2022

PEEP Setting in COVID19-related ARDS

Completed
  • ARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2
  • PEEP setting
  • Nancy, France
    Service de Réanimation Médicale, Hôpital Central
Nov 9, 2021

Ards Trial in Madrid (16-hour PP)

Completed
  • Ards
  • 16-hour PP
  • Madrid, Spain
    Hospital 12 de Octubre
Oct 27, 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • +4 more
  • (no location specified)
Sep 16, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Halifax, Saskatoon (COVAC-2, Saline Placebo)

Active, not recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • COVAC-2
  • Saline Placebo
  • Halifax, Nova Scotia, Canada
  • +1 more
Aug 5, 2022

COVID-19 Trial in Danderyd (SARS-CoV-2 convalescent plasma)

Completed
  • COVID-19
  • SARS-CoV-2 convalescent plasma
  • Danderyd, Sweden
    Danderyd Hospital
Dec 1, 2021

Clinical Features of COVID-19 Patients

Recruiting
  • Covid19
  • +2 more
  • peripheral lymphocytes subsets
  • L'Aquila, Italy
    San Salvatore Academic Hospital
Aug 12, 2021

Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients

Not yet recruiting
  • COVID-19 Pneumonia
  • ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
  • plasmatic SARS-CoV-2 RNA quantification
  • (no location specified)
Nov 9, 2021

Using Chinese Medicine During Severe Acute Respiratory Syndrome

Completed
  • COVID-19 Pandemic
  • Jing-Guan-Fang(JGF) : Chinese herbal decoction
  • Taipei, Taiwan
    Taipei City Hospital
Feb 12, 2022

Coronavirus Disease 2019 (COVID-19) on Sperm Parameters

Enrolling by invitation
  • Covid19
  • Infertility, Male
  • Sperm analysis
  • Laval, Quebec, Canada
    Fertilys
Aug 18, 2021

Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial (Stem Cell Educator-Treated Mononuclear Cells Apheresis)

Not yet recruiting
  • Severe Acute Respiratory Syndrome (SARS) Pneumonia
  • Stem Cell Educator-Treated Mononuclear Cells Apheresis
  • (no location specified)
Jun 25, 2021

Corona Virus Infection, ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2, Oxygen Deficiency Trial

Not yet recruiting
  • Corona Virus Infection
  • +2 more
  • Oxygen theraphy with high flow nasal cannule
  • Oxygen theraphy with mask with reservoir
  • Szczecin, Zachodniopomorskie, Poland
    Oxygen Therapy Sector of Temporary Hospital
Jan 18, 2022

Beaumont Health Large-scale Automated Serologic Testing for

Completed
  • COVID-19
  • +2 more
  • EUROIMMUN assay
  • Royal Oak, Michigan
  • +1 more
Sep 2, 2021

Non-invasive Oxygenation Strategies in Patients Admitted for

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • Use of High Flow Nasal Cannula alone
  • +2 more
  • Béthune, Nord-Pas-de-Calais, France
  • +3 more
Feb 1, 2022

Covid19 Trial in New Brunswick (OL-1, standard dose, OL-1, high dose, Placebo)

Completed
  • Covid19
  • OL-1, standard dose
  • +2 more
  • New Brunswick, New Jersey
    Rutgers University
Jan 31, 2022

Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • SARS-CoV2
  • Janus Kinase Inhibitor (ruxolitinib)
  • Placebo
  • Sao Paulo, Brazil
    Hospital das Clínicas
Apr 5, 2021

COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium

Terminated
  • COVID-19
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
  • C19-IG 20%
  • 0.9% Sodium chloride
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +11 more
Feb 9, 2022

Covid19 Trial in Madrid (Probiotic: Lactobacillus salivarius + Vit D + Zinc, Placebo)

Completed
  • Covid19
  • Probiotic: Lactobacillus salivarius + Vit D + Zinc
  • Placebo
  • Madrid, Spain
    Hospital Universitario Infanta Leonor
May 27, 2022

Prone Position During ECMO in Severe Acute Respiratory Syndrome

Completed
  • SARS CoV 2 Infection
  • Hypoxemic Respiratory Failure
  • Prone position on ECMO patient
  • Berkane, Morocco
    younes Oujidi
Aug 6, 2021

COVID-19 Trial (Olokizumab 64 mg, Placebo)

Withdrawn
  • COVID-19
  • Olokizumab 64 mg
  • Placebo
  • (no location specified)
Oct 29, 2021

Stratification With Chest CT to Rule-out Suspected SARS-CoV-2

Completed
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • CT-imaging
  • Jena, Thuringia, Germany
    Jena University Hospital
Sep 17, 2021

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Trial in Sumida-ku,

Completed
  • Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
  • TAK-019
  • Placebo
  • Sumida-ku, Tokyo, Japan
  • +1 more
Apr 6, 2022